title: The relation of adiponectin and tumor necrosis factor alpha levels between endothelial nitric oxide synthase, angiotensin-converting enzyme, transforming growth factor beta, and tumor necrosis factor alpha gene polymorphism in adrenal incidentalomas.
abstract: OBJECTIVE
  The aim of our study was to demonstrate demographic characteristics, presence of inflammatory markers, distribution of angiotensin-converting enzyme (ACE), tumor necrosis factor (TNF), endothelial nitric oxide synthase (eNOS) genotypes and relations among these parameters in these patients and control subjects.
  
  
  METHODS
  Study samples were collected from 50 patients with adrenal mass and 30 control groups. The eNOS, ACE, TNF-alpha, transforming growth factor (TGF)-beta genes polymorphisms, TNF-alpha, adiponectin levels were analysed in 50 unrelated Turkish patients with a diagnosis of adrenal incidentaloma (AI).
  
  
  RESULTS
  There was statistically significant difference between TNF-alpha levels of patient and controls (p=0.048). We have not detected the connection between TGF-beta, TNF-alpha, ACE, eNOS gene polymorphism with serum TNF-alpha and adiponectin levels. In this study, we demonstrated that there were significant differences for ACE genotypes in the patients when compared to the controls (p<0.05). The percentages of the ID, DD, II genotypes for ACE gene polymorphism in the patients group were 30.0, 13.0, 7.0%, respectively.
  
  
  CONCLUSIONS
  According to different cases of eNOS, TGF-beta, ACE, and TNF-alpha gene genotypes; no statistical significant difference was found between basal cortisol, ACTH, DHEAS, metanephrine, renin, aldosterone, normetanephrine, 17-hydroxyprogesterone, 1 mg low-dose dexamethasone suppression test-cortisol response and AI size. In this study, I/D genotype was determined to be statistically higher in ACE gene in patients with AI (p=0.014).
authors.affiliation: Division of Internal Medicine, Division of Endocrinology, Ege University Hospital, 35100 Izmir, Turkey.
authors.forename: E
authors.initials: E
authors.lastname: Harman
authors.forename: M
authors.initials: M
authors.lastname: Karadeniz
authors.forename: C
authors.initials: C
authors.lastname: Biray
authors.forename: A
authors.initials: A
authors.lastname: Zengi
authors.forename: S
authors.initials: S
authors.lastname: Cetinkalp
authors.forename: A G
authors.initials: AG
authors.lastname: Ozgen
authors.forename: F
authors.initials: F
authors.lastname: Saygili
authors.forename: A
authors.initials: A
authors.lastname: Berdeli
authors.forename: C
authors.initials: C
authors.lastname: Gündüz
authors.forename: C
authors.initials: C
authors.lastname: Yilmaz
mesh_terms: D052242:Adiponectin / Q000097:blood*; D000310:Adrenal Gland Neoplasms / Q000235:genetics*; D000368:Aged; D015992:Body Mass Index; D005260:Female; D005838:Genotype; D006239:Haplotypes; D006801:Humans; D033162:Incidental Findings; D008297:Male; D008875:Middle Aged; D052250:Nitric Oxide Synthase Type III / Q000235:genetics*; D007703:Peptidyl-Dipeptidase A / Q000235:genetics*; D011110:Polymorphism, Genetic; D016212:Transforming Growth Factor beta / Q000235:genetics*; D014409:Tumor Necrosis Factor-alpha / Q000235:genetics*
chemical_list: D052242:Adiponectin; D016212:Transforming Growth Factor beta; D014409:Tumor Necrosis Factor-alpha; C496314:NOS3 protein, human; D052250:Nitric Oxide Synthase Type III; D007703:Peptidyl-Dipeptidase A